King Faisal Specialist Hospital & Research Centre, Saudi Arabia
Dr. Al-Hussain completed his MBBS Degree in King Saud University, Riyadh, Kingdom of Saudi Arabia. He completed pathology training at King Faisal Specialist Hospital in 2008. Then he joined the University of North Carolina, at Chapel Hill, NC, USA, as renal pathology fellow from 2009-2010. In 2011, he completed another year of fellowship in genitourinary pathology at John Hopkins Hospital, Baltimore, USA. Currently, he is a Consultant Pathologist specializing in Nephropathology and urologic pathology.
He is also the Director of Pathology Residency Training Program. He has published 27 papers in peer reviewed journals and has been invited as speaker in several conferences locally and internationally.
Prostatic adenocarcinma is the second most common malignancy worldwide. There have been new updates on pathology of prostatic adenocarcinoma. Recently, the International Society of Urological Pathology held a consensus conference in 2014 which was published in 2015. This conference predominantly deliberated with definition of various grading patterns of usual prostatic adenocarcinoma, grading of intraductal carcinoma and the new Grade Groups. Most of these updates were implemented and applied in the new 2016 WHO Classification of Tumors of the Prostate.
The presentation will discuss the new update of prostatic adenocarcinoma with focus on grading system.